Jupiter Neurosciences

Jupiter Neurosciences EBITDA per Share

The EBITDA per Share of Jupiter Neurosciences (JUNS) as of Oct 16, 2026 is -19.40 USD. In the previous year, EBITDA per Share was -8.05 USD — a change of 140.82% (lower).

EBITDA per Share

-19.40USD

YoY

140.82%

Last updated:

EBITDA per Share of Jupiter Neurosciences is 2025 -19.40 USD. EBITDA per Share of Jupiter Neurosciences was 2024 -8.05 USD. It decreases by 140.82% lower compared to the previous year.

The Jupiter Neurosciences EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
-3.90 USD
Jan 1, 2020
-15.65 USD
Jan 1, 2021
-33.03 USD
Jan 1, 2022
-27.13 USD
Jan 1, 2023
-9.79 USD
Jan 1, 2024
-8.05 USD
Jan 1, 2025
-19.40 USD
The Jupiter Neurosciences EBITDA per Share history
YEAREBITDA per ShareYoY
-19.40USD+140.82%
-8.05USD-17.77%
-9.79USD-63.90%
-27.13USD-17.84%
-33.03USD+111.01%
-15.65USD+300.95%
-3.90USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Jupiter Neurosciences Stock analysis

What does Jupiter Neurosciences do? Jupiter Neurosciences Inc, based in Palm Beach Gardens, Florida, is a clinical-stage pharmaceutical company focused on developing treatments for neuro-inflammation. The company, with four employees, has developed JOTROL, a micellar resveratrol formulation targeting rare diseases such as Mucopolysaccharidoses Type 1, Friedreich's Ataxia, and MELAS, as well as broader conditions like Parkinson's Disease and early Alzheimer’s. JOTROL, delivered in 100mg soft gel capsules, is licensed globally from Aquanova AG for development and distribution. Jupiter Neurosciences is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jupiter Neurosciences stock

EBITDA per Share of Jupiter Neurosciences is -19.40 USD in 2025.

EBITDA per Share of Jupiter Neurosciences changed from -8.05 USD to -19.40 USD, representing a 140.82% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Jupiter Neurosciences since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Jupiter Neurosciences

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Jupiter Neurosciences